Immunogenicity of standard, high-dose, MF59-adjuvanted, and recombinant-HA seasonal influenza vaccination in older adults

The vaccine efficacy of standard-dose seasonal inactivated influenza vaccines (S-IIV) can be improved by the use of vaccines with higher antigen content or adjuvants. We conducted a randomized controlled trial in older adults to compare cellular and antibody responses of S-IIV versus enhanced vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Athena P. Y., Cohen, Carolyn A., Leung, Nancy H. L., Fang, Vicky J., Gangappa, Shivaprakash, Sambhara, Suryaprakash, Levine, Min Z., Iuliano, A. Danielle, Perera, Ranawaka A. P. M., Ip, Dennis K. M., Peiris, J. S. Malik, Thompson, Mark G., Cowling, Benjamin J., Valkenburg, Sophie A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886864/
https://www.ncbi.nlm.nih.gov/pubmed/33594050
http://dx.doi.org/10.1038/s41541-021-00289-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886864/
https://www.ncbi.nlm.nih.gov/pubmed/33594050
http://dx.doi.org/10.1038/s41541-021-00289-5

Ejemplares similares